New treatments for sepsis.
Mercier
J C
JC
Service de Réanimation Pédiatrique, Hôpital Robert-Debre, Paris, France.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D023181:Antimicrobial Cationic Peptides; D016470:Bacteremia / Q000276:immunology / Q000401:mortality / Q000628:therapy*; D001798:Blood Proteins / Q000627:therapeutic use; D015815:Cell Adhesion Molecules / Q000276:immunology; D002648:Child; D016207:Cytokines / Q000276:immunology; D004731:Endotoxins / Q000276:immunology; D015316:Genetic Therapy; D006801:Humans; D016219:Immunotherapy, Adoptive / Q000379:methods* / Q000639:trends; D008050:Lipid A / Q000276:immunology; D008565:Membrane Proteins; D009102:Multiple Organ Failure / Q000276:immunology / Q000401:mortality / Q000628:therapy; D009504:Neutrophils; D012772:Shock, Septic / Q000276:immunology / Q000401:mortality / Q000628:therapy
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D023181:Antimicrobial Cationic Peptides; D001798:Blood Proteins; D015815:Cell Adhesion Molecules; D016207:Cytokines; D004731:Endotoxins; D008050:Lipid A; D008565:Membrane Proteins; C021623:bactericidal permeability increasing protein; C068069:nebacumab